CNE100004QP1
CNE100004QP1
MEDBOT-B
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 551.069.000 | 257.249.000 | 114.2% |
| Cost of Revenue | 284.447.000 | 171.029.000 | 66.3% |
| Gross Profit | 266.622.000 | 86.220.000 | 209.2% |
| 437.645.000 | 559.784.000 | 21.8% | |
| Operating Income | -171.023.000 | -473.564.000 | 63.9% |
| Pretax Income | -254.115.000 | -647.101.000 | 60.7% |
| Net Income Common Stockholders | -249.660.000 | -642.406.000 | 61.1% |
| -- | -- | -- | |
| -- | -- | -- |